2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
David M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses cytoreductive nephrectomy for patients with renal cell carcinoma (RCC).
David M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses cytoreductive nephrectomy for patients with renal cell carcinoma (RCC).
There have been a number of retrospective analyses comparing patients who have had a cytoreductive nephrectomy versus those who did not, explains Nanus. It was clear that patients who had a cytoreductive nephrectomy experienced a higher response.
According to Nanus, if a person can undergo a cytoreductive nephrectomy they should have one as the procedure is associated with improved survival.